MARKET

VALN

VALN

Valneva Se
NASDAQ
8.92
+0.10
+1.13%
Opening 11:08 01/02 EST
OPEN
8.92
PREV CLOSE
8.82
HIGH
8.94
LOW
8.87
VOLUME
7.45K
TURNOVER
--
52 WEEK HIGH
12.25
52 WEEK LOW
4.021
MARKET CAP
765.92M
P/E (TTM)
-12.4459
1D
5D
1M
3M
1Y
5Y
1D
Valneva ends chikungunya vaccine deal with India’s Serum Institute
Seeking Alpha · 12/31/2025 17:36
Valneva Regains Full Rights to Chikungunya Vaccine as Serum Institute License Ends
TipRanks · 12/31/2025 17:08
Valneva, Serum Institute of India discontinue chikungunya vaccine pact
TipRanks · 12/31/2025 16:50
Valneva And Serum Institute Mutually Terminate Chikungunya Vaccine License; Valneva Regains Full Control To Accelerate Access In High-Risk Countries
Benzinga · 12/31/2025 16:47
VALNEVA AND SERUM INSTITUTE OF INDIA ANNOUNCE DISCONTINUATION OF CHIKUNGUNYA VACCINE LICENSE AGREEMENT
Reuters · 12/31/2025 16:45
Weekly Report: what happened at VALN last week (1222-1226)?
Weekly Report · 12/29/2025 10:33
Weekly Report: what happened at VALN last week (1215-1219)?
Weekly Report · 12/22/2025 10:33
Weekly Report: what happened at VALN last week (1208-1212)?
Weekly Report · 12/15/2025 10:41
More
About VALN
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Webull offers Valneva SE (ADR) stock information, including NASDAQ: VALN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VALN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VALN stock methods without spending real money on the virtual paper trading platform.